151 related articles for article (PubMed ID: 32741598)
1. Pharmacists are key in interpreting clinical implications of N-nitrosodimethylamine contamination in medications.
Eads AV
J Am Pharm Assoc (2003); 2020; 60(6):e100-e104. PubMed ID: 32741598
[TBL] [Abstract][Full Text] [Related]
2. Understanding and Preventing (
White CM
Ann Pharmacother; 2020 Jun; 54(6):611-614. PubMed ID: 31771343
[No Abstract] [Full Text] [Related]
3. N-nitrosodimethylamine (NDMA) contamination of ranitidine products: A review of recent findings.
Aldawsari FS; Alshehry YM; Alghamdi TS
J Food Drug Anal; 2021 Mar; 29(1):39-45. PubMed ID: 35696227
[TBL] [Abstract][Full Text] [Related]
4. Short commentary on NDMA (N-nitrosodimethylamine) contamination of valsartan products.
Snodin DJ; Elder DP
Regul Toxicol Pharmacol; 2019 Apr; 103():325-329. PubMed ID: 30629969
[TBL] [Abstract][Full Text] [Related]
5. N-Nitrosodimethylamine-Contaminated Valsartan and the Risk of Cancer—A Longitudinal Cohort Study Based on German Health Insurance Data.
Gomm W; Röthlein C; Schüssel K; Brückner G; Schröder H; Heß S; Frötschl R; Broich K; Haenisch B
Dtsch Arztebl Int; 2021 May; 118(21):357-362. PubMed ID: 34247699
[TBL] [Abstract][Full Text] [Related]
6. Analysis of an Impurity, N-Nitrosodimethylamine, in Valsartan Drug Substances and Associated Products Using GC-MS.
Tsutsumi T; Akiyama H; Demizu Y; Uchiyama N; Masada S; Tsuji G; Arai R; Abe Y; Hakamatsuka T; Izutsu KI; Goda Y; Okuda H
Biol Pharm Bull; 2019 Apr; 42(4):547-551. PubMed ID: 30726781
[TBL] [Abstract][Full Text] [Related]
7. Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study.
Pottegård A; Kristensen KB; Ernst MT; Johansen NB; Quartarolo P; Hallas J
BMJ; 2018 Sep; 362():k3851. PubMed ID: 30209057
[TBL] [Abstract][Full Text] [Related]
8. Neoplasm Reports in Food and Drug Administration Adverse Event Reporting System Following Angiotensin Receptor Blocker Recalls.
Cohen Sedgh R; Moon J; Jackevicius CA
Circ Cardiovasc Qual Outcomes; 2021 Aug; 14(8):e007476. PubMed ID: 34380327
[TBL] [Abstract][Full Text] [Related]
9. Rapid and efficient high-performance liquid chromatography analysis of N-nitrosodimethylamine impurity in valsartan drug substance and its products.
Masada S; Tsuji G; Arai R; Uchiyama N; Demizu Y; Tsutsumi T; Abe Y; Akiyama H; Hakamatsuka T; Izutsu KI; Goda Y; Okuda H
Sci Rep; 2019 Aug; 9(1):11852. PubMed ID: 31413326
[TBL] [Abstract][Full Text] [Related]
10. NDMA impurity in valsartan and other pharmaceutical products: Analytical methods for the determination of N-nitrosamines.
Parr MK; Joseph JF
J Pharm Biomed Anal; 2019 Feb; 164():536-549. PubMed ID: 30458387
[TBL] [Abstract][Full Text] [Related]
11. Lesson Learnt from Recall of Valsartan and Other Angiotensin II Receptor Blocker Drugs Containing NDMA and NDEA Impurities.
Charoo NA; Ali AA; Buha SK; Rahman Z
AAPS PharmSciTech; 2019 Apr; 20(5):166. PubMed ID: 30989447
[TBL] [Abstract][Full Text] [Related]
12. Determination of N-nitrosodimethylamine and N-nitrosomethylethylamine in drug substances and products of sartans, metformin and ranitidine by precipitation and solid phase extraction and gas chromatography-tandem mass spectrometry.
Lim HH; Oh YS; Shin HS
J Pharm Biomed Anal; 2020 Sep; 189():113460. PubMed ID: 32663759
[TBL] [Abstract][Full Text] [Related]
13. HS-SPME-GC-MS as an alternative method for NDMA analysis in ranitidine products.
Alshehri YM; Alghamdi TS; Aldawsari FS
J Pharm Biomed Anal; 2020 Nov; 191():113582. PubMed ID: 32889348
[TBL] [Abstract][Full Text] [Related]
14.
Mansouri I; Botton J; Semenzato L; Haddy N; Zureik M
J Am Heart Assoc; 2022 Dec; 11(24):e8067. PubMed ID: 36533625
[TBL] [Abstract][Full Text] [Related]
15. N-Nitrosodimethylamine (NDMA) Formation from Ranitidine Impurities: Possible Root Causes of the Presence of NDMA in Ranitidine Hydrochloride.
Yokoo H; Yamamoto E; Masada S; Uchiyama N; Tsuji G; Hakamatsuka T; Demizu Y; Izutsu KI; Goda Y
Chem Pharm Bull (Tokyo); 2021; 69(9):872-876. PubMed ID: 34470951
[TBL] [Abstract][Full Text] [Related]
16. Temperature-Dependent Formation of N-Nitrosodimethylamine during the Storage of Ranitidine Reagent Powders and Tablets.
Abe Y; Yamamoto E; Yoshida H; Usui A; Tomita N; Kanno H; Masada S; Yokoo H; Tsuji G; Uchiyama N; Hakamatsuka T; Demizu Y; Izutsu KI; Goda Y; Okuda H
Chem Pharm Bull (Tokyo); 2020 Oct; 68(10):1008-1012. PubMed ID: 32779580
[TBL] [Abstract][Full Text] [Related]
17. A Bioanalytical Method for Quantification of N-nitrosodimethylamine (NDMA) in Human Plasma and Urine with Different Meals and following Administration of Ranitidine.
De Palma R; Patel V; Florian J; Keire D; Selaya D; Strauss DG; Rouse R; Matta MK
J Pharm Sci; 2023 May; 112(5):1315-1323. PubMed ID: 36736776
[TBL] [Abstract][Full Text] [Related]
18. Effect of Oral Ranitidine on Urinary Excretion of N-Nitrosodimethylamine (NDMA): A Randomized Clinical Trial.
Florian J; Matta MK; DePalma R; Gershuny V; Patel V; Hsiao CH; Zusterzeel R; Rouse R; Prentice K; Nalepinski CG; Kim I; Yi S; Zhao L; Yoon M; Selaya S; Keire D; Korvick J; Strauss DG
JAMA; 2021 Jul; 326(3):240-249. PubMed ID: 34180947
[TBL] [Abstract][Full Text] [Related]
19. Characterization of N-nitrosodimethylamine formation from the ozonation of ranitidine.
Lv J; Wang L; Li Y
J Environ Sci (China); 2017 Aug; 58():116-126. PubMed ID: 28774600
[TBL] [Abstract][Full Text] [Related]
20. Reduction of N-nitrosodimethylamine formation from ranitidine by ozonation preceding chloramination: influencing factors and mechanisms.
Zou R; Liao X; Zhao L; Yuan B
Environ Sci Pollut Res Int; 2018 May; 25(14):13489-13498. PubMed ID: 29492817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
